Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 46 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

32%

10 of 31 completed with results

Key Signals

10 with results100% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (13)
Early P 1 (1)
P 2 (1)
P 3 (2)
P 4 (5)

Trial Status

Completed31
Unknown9
Enrolling By Invitation3
Active Not Recruiting1
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT06460389Completed

Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation With and Without Digital Assistance

NCT06064916CompletedPrimary

Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients

NCT06041139CompletedPrimary

Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

NCT05611073CompletedPrimary

Maximizing Visual Outcomes With Eyhance IOLs

NCT04692012Not ApplicableActive Not RecruitingPrimary

Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule

NCT05226884CompletedPrimary

Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

NCT06056154Enrolling By Invitation

Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design

NCT06578910Completed

Retrospective, Non-interventional Clinical Investigation of the Safety and Performance of 640AD Monofocal Intraocular Lens

NCT06578923Completed

Retrospective, Non-interventional, Comparative Clinical Investigation of the Safety and Performance of 690AD and 690ADY Monofocal Intraocular Lens Implantation With Extended Patient Enrolment

NCT04712318Not ApplicableEnrolling By InvitationPrimary

Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile

NCT04693663Not ApplicableEnrolling By InvitationPrimary

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

NCT06488066Withdrawn

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

NCT05750225Completed

Clinical Investigation of the Safety and Performance of Model 690AD and Model 690ADY Monofocal Intraocular Lens Implantation

NCT04533191Completed

Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)

NCT05418153Completed

Synergy Lens Outcomes Evaluation

NCT06260852Recruiting

Identification of Minimum Focal Points in Vision Curve Formation

NCT04011696CompletedPrimary

Monofocal Extended Range of Vision (MERoV) Study

NCT05335408Not ApplicableCompleted

Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs

NCT06065072Unknown

Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900

NCT04242875CompletedPrimary

The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens

Scroll to load more

Research Network

Activity Timeline